Search

Your search keyword '"Milder, M."' showing total 137 results
Start Over Author "Milder, M."
137 results on '"Milder, M."'

2. 6 Specifieke bestralingsapparatuur

Author

Althof, V. G. M., Dries, W. J. F., Petoukhova, A. L., Peeters, M. H. W., van den Elzen-Peeters, M. Y. G., Troost, E. G. C., van Asselen, B., Bohoudi, O., Philippens, M. E. P., Wittkamper, F. W., Milder, M. T. W., Huge, M., Smit, A. E., Dam, Tom, Series Editor, Froma, Age, Series Editor, Hakkert, Marcel, Series Editor, Hensen, Jacques, Series Editor, Scheurleer, Jelle, Series Editor, Sutherland, Iris, Series Editor, Tempelman, Gert, Series Editor, Zuurbier, Ria, Series Editor, Mast, Mirjam, editor, and Welleweerd, Hans, editor

Published
2020
Full Text
View/download PDF

4. 6 Specifieke bestralingsapparatuur

Author

Althof, V. G. M., primary, Dries, W. J. F., additional, Petoukhova, A. L., additional, Peeters, M. H. W., additional, van den Elzen-Peeters, M. Y. G., additional, Troost, E. G. C., additional, van Asselen, B., additional, Bohoudi, O., additional, Philippens, M. E. P., additional, Wittkamper, F. W., additional, Milder, M. T. W., additional, Huge, M., additional, and Smit, A. E., additional

Published
2019
Full Text
View/download PDF

7. Psychometric properties of the French Hot Flash Related Daily Interference Scale (HFRDIS).

Author

Cavadias, I., Rouzier, R., Milder, M., Bonneau, C., Mullaert, J., and Hequet, D.

Subjects
HOT flashes, PSYCHOMETRICS, CANCER hormone therapy, BREAST cancer, FRENCH people
Abstract

Copyright of Climacteric is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

12. Stereotactic Body Radiation Therapy Following Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Feasibility Study

Author

Baak, R., primary, Willemssen, F.E.J.A., additional, van Norden, Y., additional, Milder, M., additional, Heijmen, B.J.M., additional, Eskens, F.A.L.M., additional, Koerkamp, B. Groot, additional, Sprengers, D., additional, van Driel, L.M.J.W., additional, Klümpen, H.J., additional, den Toom, W., additional, Koedijk, M.S., additional, and Romero, A. Mendez, additional

Published
2021
Full Text
View/download PDF

19. Treatment planning for spinal radiosurgery: A competitive multiplatform benchmark challenge|Bestrahlungsplanung für Wirbelsäulen-Radiochirurgie: Eine kompetitive Multiplattform-Benchmark-Studie

Author

Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O., and Moustakis C, Chan MKH, Kim J, Nilsson J, Bergman A, Bichay TJ, Palazon Cano I, Cilla S, Deodato F, Doro R, Dunst J, Eich HT, Fau P, Fong M, Haverkamp U, Heinze S, Hildebrandt G, Imhoff D, de Klerck E, Köhn J, Lambrecht U, Loutfi-Krauss B, Ebrahimi F, Masi L, Mayville AH, Mestrovic A, Milder M, Morganti AG, Rades D, Ramm U, Rödel C, Siebert FA, den Toom W, Wang L, Wurster S, Schweikard A, Soltys SG, Ryu S, Blanck O.

Subjects
Organs at Risk, Robotic Surgical Procedure, Radiotherapy Planning, Computer-Assisted, Spinal Neoplasm, Radiotherapy Dosage, Multiplatform, Radiosurgery, Thoracic Vertebrae, Re-Irradiation, Algorithm, Benchmarking, Stereotactic body radiation therapy, Spinal radiosurgery, Benchmark study, Radiotherapy, Intensity-Modulated, Neoplasm Recurrence, Local, Multicenter, Dose Fractionation, Treatment planning challenge, Aged, Human
Abstract

To investigate the quality of treatment plans of spinal radiosurgery derived from different planning and delivery systems. The comparisons include robotic delivery and intensity modulated arc therapy (IMAT) approaches. Multiple centers with equal systems were used to reduce a bias based on individual's planning abilities. The study used a series of three complex spine lesions to maximize the difference in plan quality among the various approaches.

Published
2018

20. A Multi-Platform Treatment Planning Benchmark Study for Spinal Radiosurgery

Author

Moustakis, C., primary, Chan, M.K.H., additional, Kim, J., additional, Nilsson, J., additional, Bergman, A., additional, Bichay, T.J., additional, Cilla, S., additional, Deodato, F., additional, Doro, R., additional, Eich, H.T.T., additional, Fau, P., additional, Fong, M., additional, Haverkamp, U., additional, Heinze, S., additional, Köhn, J., additional, de Klerck, E.C., additional, Lambrecht, U., additional, Masi, L., additional, Mayville, A.H., additional, Morganti, A.G., additional, Milder, M., additional, Rades, D., additional, Ramm, U., additional, Ryu, S., additional, Soltys, S.G., additional, Tazeh Maha, F. Ebrahimi, additional, Toom, W. den, additional, Wang, L., additional, and Blanck, O., additional

Published
2019
Full Text
View/download PDF

21. PV-103 Linking ACROP guidelines to ICRU91: a multicentre study in lung SBRT on prescription and reporting

Author

De Jong, E., primary, Guckenberger, M., additional, Andratschke, N., additional, Dieckmann, K., additional, Hoogeman, M.S., additional, Milder, M., additional, Moller, D. Sloth, additional, Nyeng, T. Bisballe, additional, Tanadini-Lang, S., additional, Lartigau, E., additional, Lacornerie, T., additional, Romero, A. Mendez, additional, Verbakel, W., additional, Verellen, D., additional, De Kerf, G., additional, and Hurkmans, C.W., additional

Published
2019
Full Text
View/download PDF

23. Fully automated, multi-criterial planning for Volumetric Modulated Arc Therapy – An international multi-center validation for prostate cancer

Author

Heijmen, B, Voet, P, Fransen, D, Penninkhof, J, Milder, M, Akhiat, H, Bonomo, Pierluigi, Casati, Marta, Georg, D, Goldner, G, Henry, A, Lilley, J, Lohr, F, Marrazzo, Livia, Pallotta, Stefania, Pellegrini, R, Seppenwoolde, Y, Simontacchi, Gabriele, Steil, V, Stieler, F, Wilson, S, and Breedveld, S

Subjects
Automated multi-criterial treatment planning, Knowledge-based planning, Multi-center validation, Prostate, VMAT
Published
2018

24. Les deux faces du confinement. Préoccupations et satisfactions des personnes atteintes de cancer pendant le confinement.

Author

Mino, J.-C., Carton, M., Bredart, A., Milder, M., and Renault-Tessier, E.

Abstract

Copyright of Psycho-Oncologie is the property of PiscoMed Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2020
Full Text
View/download PDF

25. OC-0299: Inconsistencies in clinicians‘ final treatment plan evaluations – a need for automation support

Author

Heijmen, B., primary, Bonomo, P., additional, Goldner, G., additional, Henry, A., additional, Lohr, F., additional, Simontacchi, G., additional, Voet, P., additional, Fransen, D., additional, Penninkhof, J., additional, Milder, M., additional, Akhiat, A., additional, Casati, M., additional, Georg, D., additional, Lilley, J., additional, Marrazzo, L., additional, Pallotta, S., additional, Pellegrini, R., additional, Seppenwoolde, Y., additional, Steil, V., additional, Stieler, F., additional, Wilson, S., additional, and Breedveld, S., additional

Published
2018
Full Text
View/download PDF

30. Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer

Author

Pierga, J.-Y., primary, Riva, F., additional, Houy, A., additional, Saliou, A., additional, Madic, J., additional, Rampanou, A., additional, Hego, C., additional, Milder, M., additional, Cottu, P., additional, Sablin, M.-P., additional, Vincent-Salomon, A., additional, Lantz, O., additional, Stern, M.-H., additional, Proudhon, C., additional, and Bidard, F.-C., additional

Published
2016
Full Text
View/download PDF

32. OC-0268: Fully automated VMAT plan generation – an international multi-institutional validation study

Author

Heijmen, B., primary, Voet, P., additional, Fransen, D., additional, Akhiat, H., additional, Bonomo, P., additional, Casati, M., additional, Georg, D., additional, Goldner, G., additional, Henry, A., additional, Lilley, J., additional, Lohr, F., additional, Marrazzo, L., additional, Milder, M., additional, Pallotta, S., additional, Penninkhof, J., additional, Seppenwoolde, Y., additional, Simontacchi, G., additional, Steil, V., additional, Stieler, F., additional, Wilson, S., additional, Pellegrini, R., additional, and Breedveld, S., additional

Published
2016
Full Text
View/download PDF

33. 1810 Neoadjuvant chemotherapy modifies the immune status of tumor-draining lymph nodes of breast cancer patients: Implications for immunotherapy

Author

Nunez, N., primary, Loirat, D., additional, De La Rochere, P., additional, Nadan, A.T., additional, Sastre-Garau, X., additional, Meseure, D., additional, Diéras, V., additional, Milder, M., additional, Viel, S., additional, Sedlik, C., additional, Amigorena, S., additional, and Piaggio, P., additional

Published
2015
Full Text
View/download PDF

43. Selection and classification of high school volleyball players from performance tests.

Author

Thissen-Milder, M. and Mayhew, J.L.

Subjects
SPORTS medicine
Abstract

Presents a study that determines the accuracy of general and specific tests for identifying the players on freshmen, junior varsity and varsity teams, and the precision of tests to differentiate between starters and nonstarters at each level of play. Methods; Results; Discussion.

Published
1991

46. Carrier Multiplication and Its Reduction by Photodoping in Colloidal InAs Quantum Dots

Author

J. H. Pijpers, J., Hendry, E., T. W. Milder, M., Fanciulli, R., Savolainen, J., L. Herek, J., Vanmaekelbergh, D., Ruhman, S., Mocatta, D., Oron, D., Aharoni, A., Banin, U., and Bonn, M.

Abstract

Carrier (exciton) multiplication in colloidal InAs/CdSe/ZnSe core−shell quantum dots (QDs) is investigated using terahertz time-domain spectroscopy, time-resolved transient absorption, and quasi-continuous wave excitation spectroscopy. For excitation by high-energy photons (∼2.7 times the band gap energy), highly efficient carrier multiplication (CM) results in the appearance of multi-excitons, amounting to ∼1.6 excitons per absorbed photon. Multi-exciton recombination occurs within tens of picoseconds via Auger-type processes. Photodoping (i.e., photoinjection of an exciton) of the QDs prior to excitation results in a reduction of the CM efficiency to ∼1.3. This exciton-induced reduction of CM efficiency can be explained by the twofold degeneracy of the lowest conduction band energy level. We discuss the implications of our findings for the potential application of InAs QDs as light absorbers in solar cells.

Published
2007
Full Text
View/download PDF

49. Real-World Survival Impact of New Treatment Strategies for Lung Cancer: A 2000-2020 French Cohort.

Author

Basse C, Carton M, Milder M, Geiss R, Du Rusquec P, Daniel C, Massiani MA, Livartowski A, and Girard N

Abstract

Over the past 20 years, several innovative therapies have been implemented in the treatment of lung cancer that have had reported survival benefits in clinical trials. Whether these improvements translate into the clinic setting has not been studied yet. We retrospectively analyzed all patients consecutively treated at Institute Curie for metastatic lung cancer. Diagnosis date was used to define three periods, based on the approvals of novel treatment strategies in the first-line setting, including targeted therapies in 2010 and immunotherapy in 2018. Endpoints included Overall survival (OS), survival rate of 2 years and 5 years, and a conditional survival rate of 2 years (if still alive at 6 months from treatment initiation). A total of 673 patients were identified for Period 1-2000 to 2009, 752 for Period 2-2010 to 2017, and 768 for Period 3-2018 to 2020. Median OS in the whole cohort was 11.1, 15.5, and 16.2 months, respectively. Median OS for patients with NSCLC or SCLC was 11.2, 17.2, and 18.2 months, or 10.9, 11.7, and 11.2 months, respectively. The two-year conditional survival was more favorable for NSCLC than SCLC patients. Outcomes were statistically higher for women as compared to men in all periods and all subgroups. Survival of patients with metastatic lung cancer has improved over the past 20 years, mostly in NSCLC, along with the implementation of novel treatment strategies.

Published
2024
Full Text
View/download PDF

50. Comparison of stereotactic radiotherapy and protons for uveal melanoma patients.

Author

Fleury E, Pignol JP, Kiliç E, Milder M, van Rij C, Naus N, Yavuzyigitoglu S, den Toom W, Zolnay A, Spruijt K, van Vulpen M, Trnková P, and Hoogeman M

Abstract

Background and Purpose: Uveal melanoma (UM) is the most common primary ocular malignancy. We compared fractionated stereotactic radiotherapy (SRT) with proton therapy, including toxicity risks for UM patients., Materials and Methods: For a total of 66 UM patients from a single center, SRT dose distributions were compared to protons using the same planning CT. Fourteen dose-volume parameters were compared in 2-Gy equivalent dose per fraction (EQD2). Four toxicity profiles were evaluated: maculopathy, optic-neuropathy, visual acuity impairment (Profile I); neovascular glaucoma (Profile II); radiation-induced retinopathy (Profile III); and dry-eye syndrome (Profile IV). For Profile III, retina Mercator maps were generated to visualize the geographical location of dose differences., Results: In 9/66 cases, (14 %) proton plans were superior for all dose-volume parameters. Higher T stages benefited more from protons in Profile I, especially tumors located within 3 mm or less from the optic nerve. In Profile II, only 9/66 cases resulted in a better proton plan. In Profile III, better retina volume sparing was always achievable with protons, with a larger gain for T3 tumors. In Profile IV, protons always reduced the risk of toxicity with a median RBE-weighted EQD2 reduction of 15.3 Gy., Conclusions: This study reports the first side-by-side imaging-based planning comparison between protons and SRT for UM patients. Globally, while protons appear almost always better regarding the risk of optic-neuropathy, retinopathy and dry-eye syndrome, for other toxicity like neovascular glaucoma, a plan comparison is warranted. Choice would depend on the prioritization of risks., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: E. Fleury: The Department of Radiotherapy (Erasmus Medical Center Cancer Institute, The Netherlands) has research collaborations with Elekta AB, Stockholm, Sweden, Accuray Inc., Sunnyvale, CA, USA, Varian, Palo Alto, CA, USA, RaySearch Laboratories, Stockholm, Sweden, outside the submitted work. Prof. dr. Pignol: Prof. dr. Pignol was senior vice president, chief medical and technology officer at Accuray Inc., Sunnyvale, CA, USA until February 2023. Prof. dr. Hoogeman: Prof. dr. Hoogeman reports grants from Netherlands Organization for Scientific Research, grants from Varian, a Siemens Healthineers Company, Palo Alto, California, USA, during the conduct of the study; being a Member of advisory board Accuray, Sunnyvale, USA; being a participant/presenter at Accuray Thinktank Meeting on Prostate cancer, outside the submitted work; and The Department of Radiotherapy (Erasmus Medical Center Cancer Institute, The Netherlands) has research collaborations with Elekta AB, Stockholm, Sweden, Accuray Inc., Sunnyvale, CA, USA, Varian, Palo Alto, CA, USA, RaySearch Laboratories, Stockholm, Sweden, outside the submitted work., (© 2024 The Authors.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results